Mechanisms of Leptin Resistance

瘦素抵抗机制

• 批准号: 7642800
• 负责人: Zachary A. Knight
• 金额: $ 8.96万
• 依托单位: ROCKEFELLER UNIVERSITY
• 依托单位国家: 美国
• 财政年份: 2009
• 资助国家: 美国
• 起止时间: 2009-04-05 至 2011-03-31
• 项目状态: 已结题
• 来源: https://reporter.nih.gov/project-details/7642800
• 关键词: Address; Adipocytes; Adipose tissue; Adult; Animal Model; Animals; Body Weight; Body Weight decreased; Body fat; Cell Line; Cells; Chronic; Complex; Development; Diet; Dietary Fats; Drug Delivery Systems; Eating; Environment; Epitopes; Event; Fatty acid glycerol esters; Feedback; Gene Expression; Gene Expression Profiling; Genes; Genetic; Goals; Hormones; Human; Hypothalamic structure; Laboratories; Laboratory Research; Lead; Leptin; Leptin resistance; Literature; Measures; Mentors; Messenger RNA; Metabolic; Metabolic Diseases; Modeling; Molecular; Mus; Neurons; Obese Mice; Obesity; Pathway interactions; Pharmaceutical Preparations; Phase; Physiological; Physiology; Plasma; Principal Investigator; Public Health; RNA Interference; Reporting; Research; Resistance; Resistance development; Ribosomes; Rodent Model; Role; Signal Pathway; Signal Transduction; Signaling Molecule; Signaling Pathway Gene; Study models; Synthesis Chemistry; Testing; Transgenic Mice; Universities; Weight; base; career; diabetes risk; feeding; fly; hypertensive heart disease; in vivo; mouse model; new technology; new therapeutic target; novel; novel strategies; obesity treatment; promoter; public health relevance; research study; response; small molecule; therapeutic target

DESCRIPTION (provided by applicant): Leptin is a hormone secreted by adipocytes that acts as the major signal in a negative feedback loop controlling bodyweight. Leptin treatment of leptin deficient (ob/ob) mice and humans results in profound weight loss, but more common diet-induced obesity is associated with high plasma leptin levels and resistance to leptin's weight-reducing effects. The molecules and signaling pathways that are responsible for the development of leptin resistance are largely unknown, but such molecules would be attractive targets for obesity therapy. This application describes experiments that will clarify the physiological events that lead to leptin resistance and identify candidates that represent novel cellular regulators of leptin sensitivity. These experiments make use of new approaches and models that overcome one of the key technical challenges that has frustrated efforts to study leptin resistance: the difficulty of accessing leptin's direct target cells, a small subset of neurons dispersed throughout the hypothalamus. Finally, the physiological function of candidate leptin regulators will be explored in rodent models of obesity, using a combination of genetic, anatomical, and pharmacological approaches. Special emphasis will be placed on the use of small molecule drugs, accessed through synthetic chemistry, to rapidly validate candidates in vivo. This research plan will help advance my career goal to lead an interdisplinary research laboratory that applies my background in synthetic chemistry and small molecule discovery to address questions in obesity and metabolic disease. The mentored phase of this research will be conducted in the laboratory of Jeffrey Friedman at Rockefeller University, who has been a leader in field of molecular obesity research. PUBLIC HEALTH RELEVANCE: Obesity is a major public heath problem. This research seeks to understand basic mechanisms that control body weight and identify novel drug targets for obesity therapy.

描述(由申请人提供)： 瘦素是一种由脂肪细胞分泌的激素，是控制体重的负反馈循环中的主要信号。瘦素缺乏(ob/ob)小鼠和人类的瘦素治疗可显著减轻体重，但更常见的饮食诱导肥胖与高血浆瘦素水平和抵抗瘦素的减肥作用有关。导致瘦素抵抗发展的分子和信号通路在很大程度上尚不清楚，但这些分子将成为肥胖症治疗的诱人靶点。本申请描述的实验将阐明导致瘦素抵抗的生理事件，并确定代表瘦素敏感性的新细胞调节因子的候选对象。这些实验使用了新的方法和模型，克服了阻碍瘦素抵抗研究努力的关键技术挑战之一：访问瘦素的直接靶细胞的困难，瘦素直接靶细胞是分布在下丘脑的一小部分神经元。最后，将结合遗传学、解剖学和药理学的方法，在肥胖的啮齿动物模型中探索候选瘦素调节剂的生理功能。将特别强调通过合成化学获得的小分子药物的使用，以在体内快速验证候选药物。这项研究计划将有助于推进我的职业目标，领导一个跨学科的研究实验室，利用我在合成化学和小分子发现方面的背景来解决肥胖和代谢性疾病的问题。这项研究的指导阶段将在洛克菲勒大学的杰弗里·弗里德曼的实验室进行，他一直是分子肥胖症研究领域的领导者。 与公共健康相关：肥胖是一个主要的公共健康问题。这项研究试图了解控制体重的基本机制，并确定肥胖症治疗的新药物靶点。